IRVINE, CA--(Marketwire - December 23, 2008) - Edwards Lifesciences Corporation (NYSE: EW), a
world leader in products and technologies to treat advanced cardiovascular
disease, announced today it will voluntarily disclose financial
relationships with U.S. physicians starting in 2009.
"Edwards has always been proud of its relationships with clinicians, which
led to the development of the first commercially available artificial heart
valve and the establishment of our company 50 years ago. Medical
innovation is dependent on these physician partnerships, and we believe
that bringing transparency to these relationships will help the public
better understand the critical role they play in the advancement of medical
technology and patient care," said Michael A. Mussallem, Edwards' chairman
Edwards plans to begin posting on a page on its web site its financial
relationships with physicians who receive $5,000 or more a year in
consulting fees, royalties or honoraria from Edwards. The company will
begin targeted tracking of this data on January 1, 2009, and will publish
it annually beginning in the second half of 2009.
"We've been supportive of federal legislation that would require all
companies to disclose this information. As we build the systems to improve
tracking and reporting of this kind of information, we anticipate
implementing an even more comprehensive disclosure policy in future years.
In the meantime, we hope that launching this voluntary program in advance
of a federal mandate can help inform the debate as we learn from our
experience," said Mussallem.
About Edwards Lifesciences
Edwards Lifesciences is the global leader in the science of heart valves
and hemodynamic monitoring. Headquartered in Irvine, Calif., Edwards treats
advanced cardiovascular disease with its market-leading heart valve
therapies, and critical care and vascular technologies. In 2008, Edwards
celebrates 50 years of partnering with clinicians to develop life-saving
innovations. The company's global brands, which are sold in approximately
100 countries, include CardioVations, Carpentier-Edwards, Cosgrove-Edwards,
FloTrac, Fogarty, PERIMOUNT Magna and Swan-Ganz. Additional company
information can be found at http://www.edwards.com.
Edwards is a trademark of Edwards Lifesciences Corporation. Edwards
Lifesciences, the stylized E logo, Carpentier-Edwards, Cosgrove-Edwards,
FloTrac, Fogarty, Magna, PERIMOUNT Magna and Swan-Ganz are trademarks of
Edwards Lifesciences Corporation and are registered in the United States
Patent and Trademark Office. CardioVations is a trademark of Edwards
Lifesciences AG and is registered in the United States Patent and Trademark